Clinical Practice

Talking About Food Markers With the Patient Who Has Already Been Told It's Nothing

How to structure the consultation with patients presenting vague fatigue, digestive or inflammatory complaints, including what to say about prior negative allergy testing and what not to promise.

Most clinicians recognise the presentation. A patient arrives with fatigue that has lasted months, intermittent bloating, maybe stiffness that migrates, and a folder of unremarkable results. Somewhere in the history is a scratch test that came back clear, and the patient has drawn a reasonable conclusion from it: food is not the problem. That conclusion may be correct. It may also rest on a test that only measured one thing.

The conversation you have before ordering any further testing determines how the results get used. Done well, it sets a frame the patient can hold onto through an elimination phase. Done poorly, it produces a patient who expects a list of forbidden foods and a cure, and who is disappointed by anything less.

Separate what was measured from what was concluded

A skin prick or specific IgE test measures the mechanism behind immediate, mast-cell-mediated allergy. That is a genuinely useful thing to know, and it is not the same question as whether a delayed immune response is being mounted against foods the patient eats regularly. When a patient says testing showed nothing, it is worth asking what was actually run. Often the honest answer is that immediate allergy was ruled out and delayed markers were never looked at.

This is a factual clarification rather than a promise. You are telling the patient that a different question can be asked, not that asking it will explain their symptoms. NIH studies indicate at least 20 percent of the American population have food sensitivities, so the possibility is not remote. It is still a possibility.

Say plainly what the panel measures

IS382 COMPLETE measures four immune markers linked to 382 foods: IgE for immediate allergy, IgG and IgG4 for delayed responses, and complement C3b/d. The wording that holds up in a consultation is that the panel measures markers linked to foods, and that you will interpret those markers alongside the patient's history, timing of symptoms and diet.

The complement result is usually the part worth explaining, because patients rarely know it exists. Complement activation can amplify a reaction substantially, which means two foods with similar antibody results may not behave the same way clinically. That distinction is the reason a multi-marker panel gives you more to work with than a single-marker one, and it is also the reason the report needs a clinician reading it rather than a patient reading it alone.

A short version that works in the room:

• The markers describe immune activity, not a diagnosis
• A high result is a lead to test in practice, not an instruction
• Some foods on the report will turn out to be irrelevant to how the patient feels

The chiropractic framing

For chiropractors, the entry point is different. The patient is not usually asking about food. They are asking why the same segment keeps needing attention, or why recovery between visits is slower than the mechanical picture suggests. Systemic inflammatory load is a legitimate part of that conversation, and food markers are one input into assessing it.

The useful sentence is that you are looking at whether something is keeping the tissue environment reactive between adjustments. It keeps the test inside your scope, positions it as adjunctive, and avoids implying that a serum panel will resolve a structural complaint.

For dietitians, the conversation is the deliverable

In a virtual nutrition practice, the intake conversation is most of the service. A 382-food report gives that conversation structure it otherwise has to invent, and it changes the sequence of the engagement. Instead of open-ended food journaling until patterns emerge, you begin with marker data, cross-reference it against what the patient actually eats, and build a staged plan from the overlap.

That is worth pricing as a diagnostic and interpretation service rather than folding into a general consult. The at-home serum collection means the testing step adds no clinic visit and no equipment, so the billable work stays where your expertise is: reading the report and building the protocol.

Union members and the cost question

Where members access testing at no cost through insurance, one common objection disappears before it is raised. That changes the tone of the conversation. You are no longer justifying a spend against uncertain benefit; you are deciding whether the clinical question is worth asking. It also means the follow-up appointment matters more than usual, because a report the member never sits down and reviews with a clinician is a wasted opportunity.

What not to say

Do not promise the results will explain the fatigue. Do not describe the panel as identifying sensitivities or diagnosing anything. Do not suggest that removing flagged foods will resolve a condition. The defensible position is narrower and more durable: these markers give you information you did not have, you will interpret it in context, and the plan you build from it will be tested in practice.

Book the follow-up when you order the test. The interpretation appointment is where the clinical value sits, and patients who leave without one on the calendar are the ones who end up reading their own report.